Publikationen in Zusammenarbeit mit Forschern von Hospital Clinico Universitario de Valencia (23)

2024

  1. New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2021

  1. Activation of the constitutive androstane receptor inhibits leukocyte adhesiveness to dysfunctional endothelium

    International Journal of Molecular Sciences, Vol. 22, Núm. 17

2020

  1. Pharmacological modulation of redox signaling pathways in disease

    Free Radical Biology and Medicine

2018

  1. Applicability of the STOPP/START criteria to older polypathological patients in a long-term care hospital

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 6, pp. 310-316

  2. Investigation of different iontophoretic currents profiles for short-term applications in cosmetics

    Pharmaceutics, Vol. 10, Núm. 4

2017

  1. Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review

    Nutrition and Cancer, Vol. 69, Núm. 4, pp. 555-563

  2. Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats

    Biopharmaceutics and Drug Disposition, Vol. 38, Núm. 5, pp. 315-325

  3. Population pharmacokinetics of lenalidomide in multiple myeloma patients

    Cancer Chemotherapy and Pharmacology, Vol. 79, Núm. 1, pp. 189-200

2016

  1. A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies

    Journal of Laboratory Automation, Vol. 21, Núm. 6, pp. 806-810

  2. A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients

    International Journal of Antimicrobial Agents, Vol. 47, Núm. 3, pp. 184-194

  3. Fit-for-purpose chromatographic method for the determination of amikacin in human plasma for the dosage control of patients

    Talanta, Vol. 150, pp. 510-515

2015

  1. Impact of nutritional status on the pharmacokinetics of erlotinib in rats

    Biopharmaceutics and Drug Disposition, Vol. 36, Núm. 6, pp. 373-384

2011

  1. Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra

    Magnetic Resonance Materials in Physics, Biology and Medicine, Vol. 24, Núm. 1, pp. 35-42

  2. Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosis

    Journal of Biomedical Informatics, Vol. 44, Núm. 4, pp. 677-687

2009

  1. Determination of metabolite concentrations in human brain tumour biopsy samples using HR-MAS and ERETIC measurements

    NMR in Biomedicine, Vol. 22, Núm. 2, pp. 199-206

2007

  1. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis

    Neurology, Vol. 69, Núm. 1, pp. 63-67

  2. Relación entre el volumen lesional cerebral total en resonancia magnética secuencia T 2 y el daño neuroaxonal en la sustancia blanca aparentemente normal del tronco del encéfalo en la esclerosis múltiple remitente-recurrente

    Revista de Neurologia, Vol. 45, Núm. 8, pp. 468-473

  3. Stability studies of binary mixtures of haloperidol and/or midazolam with other drugs for parenteral administration

    Journal of Palliative Medicine, Vol. 10, Núm. 6, pp. 1306-1311

2006

  1. An observation of interest relative to the practice of spectroscopic measurements in multiple sclerosis [3]

    American Journal of Neuroradiology

2005

  1. Magnetic resonance myelography evaluation of the lumbar spine end plates and intervertebral disks

    Acta Radiologica, Vol. 46, Núm. 1, pp. 83-88